Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Diabetes Research and Clinical Practice|June 3, 2008
CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseasesMasafumi Koga, Soji Kasayama, Hideo Kanehara, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 20, 2015
Is glycated albumin useful for differential diagnosis between fulminant type 1 diabetes mellitus and acute-onset autoimmune type 1 diabetes mellitus?Masafumi Koga, Hideo Kanehara, Yukihiro Bando, et al.
World Journal of Gastroenterology|July 4, 2015
Liver fibrosis markers of nonalcoholic steatohepatitisHirayuki Enomoto, Yukihiro Bando, Hideji Nakamura, et al.
Diabetes Research and Clinical Practice|December 29, 2004
Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibodyTsuguhito Ota, Toshinari Takamura, Yukihiro Nagai, et al.
Endocrine Journal|July 21, 2007
Myxedema ascites with an extremely elevated CA125 Level: a case reportHideo Kanehara, Yukihiro Bando, Manabu Tomita, et al.
Annals of Clinical Biochemistry|August 14, 2009
Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver diseaseYukihiro Bando, Hideo Kanehara, Daisyu Toya, et al.
Journal of Diabetes Investigation|May 21, 2014
Obesity may attenuate the HbA1c-lowering effect of sitagliptin in Japanese type 2 diabetic patientsYukihiro Bando, Hideo Kanehara, Keiko Aoki, et al.
Diabetes Research and Clinical Practice|January 3, 2009
Characteristics of undiagnosed diabetes mellitus in a population undergoing health screening in Japan: target populations for efficient screeningYukihiro Bando, Hideo Kanehara, Keiko Aoki, et al.
Journal of Clinical & Translational Endocrinology|October 26, 2017
Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitusYukihiro Bando, Hitomi Tohyama, Keiko Aoki, et al.
Diabetes Research and Clinical Practice|November 22, 2015
Switching from atorvastatin to rosuvastatin lowers small, dense low-density lipoprotein cholesterol levels in Japanese hypercholesterolemic patients with type 2 diabetes mellitusYukihiro Bando, Hitomi Toyama, Hideo Kanehara, et al.
Pageof 3